Checks how well the Figure-of-Eight Walk and Weight-Bearing Lunge tests measure movement in adults with hemophilia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study evaluates the validity and reliability of the Figure-of-Eight Walk Test and the Weight-Bearing Lunge Test in adults with hemophilia. Participants are adults aged 18-65 with varying severities of hemophilia A and a history of knee or ankle bleeding. The analysis focuses on how consistently these tests measure functional mobility and joint impact, informing their use in clinical assessment and rehabilitation. No interventions are described beyond the administration of the tests, and eligibility requires independent walking ability and absence of recent major surgery or active joint bleeding. Results will help determine whether these tests are appropriate outcome measures for mobility in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* a diagnosis of hemophilia A
* severe, moderate or mild clinical severity of hemophilia
* a history of bleeding in at least one knee or ankle joint
* being aged 18-65
* the ability to walk 20 meters independently without a cane or crutches

Exclusion Criteria:

* inability to stand unsupported; presence of an orthopaedic, neurological, and/or psychiatric condition affecting balance or physical performance
* visual impairment
* inhibitor positivity
* inability to bear weight through the lower extremities
* major lower-extremity surgery within the previous 6 months
* haemarthrosis within the previous 2 weeks.

Where it's running

• Van Yuzuncu Yil University
  Van, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Necati Muhammed TAT, Assistant Professor
• Email: necatimuhammedtat@yyu.edu.tr
• Phone: +905075083347

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized Hemophilia Care Through Telemedicine and Adherence Monitoring

  This study tests a telemedicine-based program to closely monitor bleeding, ensure patients stick to their treatment plan, and personalize care for adults with hemophilia who use a smartphone.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07867834

• Multimodal Telerehabilitation vs Face-to-Face Care for Adults with Hemophilia and Chronic Pain

  This trial tests whether a 6-week telerehabilitation program combining pain education and therapeutic exercise works as well as in-person care for adults with hemophilia and chronic pain.

  Recruiting University of Chile · Santiago, Santiago Metropolitan · NCT07682519

• PCC treatment for hemophilia A patients with inhibitors

  This trial tests whether giving prothrombin complex concentrate (PCC) during bleeding episodes can stop bleeds in people aged 12–65 with hemophilia A who have inhibitors.

  Recruiting Phase 4 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07406139

• Fitusiran prophylaxis for boys aged 1 to under 12 with severe hemophilia A or B

  This study tests whether fitusiran given as prophylaxis can reduce bleeding in boys aged 1 to under 12 with severe hemophilia A or B, with or without inhibitors.

  Recruiting at 37 sites Phase 3 Sanofi · Los Angeles, California and 36 other locations · NCT07285460

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

• Monitoring anti‑TFPI antibodies in adult men with severe hemophilia

  This project tests blood-based lab methods to monitor anti-TFPI antibodies in adult men with severe hemophilia who are on prophylaxis.

  Recruiting Hospices Civils de Lyon · Bron and 1 other locations · NCT07101926

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.